NanoViricides, Inc. (NNVC) stock
NNVCNYSEPharmaceutical PreparationsFiscal year ends June 30
$1.23−0.12 (-8.89%)
Close on Nov 13, 2026Market cap $31.40MP/E –Yield –
NanoViricides enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
NanoViricides's enterprise value was $28.96M on Nov 11, 2026, against $20.29M a year earlier. Over the last 5 years it ranged from -$149.51K to $35.32M, with a median of $14.34M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $28.96M | +54.7% |
| 2025 | Dec 31, 2025 | $18.71M | +15.2% |
| 2024 | Dec 31, 2024 | $16.24M | +149.5% |
| 2023 | Dec 29, 2023 | $6.51M | – |
| 2022 | Dec 30, 2022 | -$30.90K | -100.1% |
| 2021 | Dec 31, 2021 | $23.18M | +162.8% |
| 2020 | Dec 31, 2020 | $8.82M | +0.2% |
| 2019 | Dec 31, 2019 | $8.80M | +12.9% |
| 2018 | Dec 31, 2018 | $7.79M | -81.5% |
| 2017 | Dec 29, 2017 | $42.23M | -8.3% |
| 2016 | Dec 30, 2016 | $46.05M | +19.7% |
| 2015 | Dec 31, 2015 | $38.47M | -65.9% |
| 2014 | Dec 31, 2014 | $112.65M | -49.8% |
| 2013 | Dec 31, 2013 | $224.54M | +265.0% |
| 2012 | Dec 31, 2012 | $61.51M | -22.6% |
| 2011 | Dec 30, 2011 | $79.49M | -57.0% |
| 2010 | Dec 31, 2010 | $184.88M | – |
See a number that looks wrong?